Diagnosis of early pancreas graft failure via antibody-mediated rejection: Single-center experience with 256 pancreas transplantations

American Journal of Transplantation

Volumn 14, Issue 4, 2014, Pages 936-942

  De Kort, H ^a,c   Mallat, M J K ^a   Van Kooten, C ^a   De Heer, E ^a   Brand Schaaf, S H ^a   Van Der Wal, A M ^a   Roufosse, C ^b   Roelen, D L ^a   Bruijn, J A ^a   Claas, F H ^a   De Fijter, J W ^a   Bajema, I M ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b IMPERIAL COLLEGE HEALTHCARE NHS TRUST   (United Kingdom)

^c ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Antibodies; antibody mediated rejection; complement C4d; graft rejection; histopathology; pancreas transplantation

Indexed keywords

ANTIBODY; COMPLEMENT COMPONENT C4D; ALLOANTIBODY; COMPLEMENT C4D; COMPLEMENT COMPONENT C4B; PEPTIDE FRAGMENT;

ADULT; ALLOGRAFT; ANTIBODY MEDIATED REJECTION; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; EARLY PANCREAS GRAFT FAILURE; FEMALE; FOLLOW UP; GRAFT FAILURE; GRAFT SURVIVAL; HISTOLOGY; HISTOPATHOLOGY; HUMAN; INCIDENCE; KIDNEY GRAFT; KIDNEY PANCREAS TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PANCREAS TRANSPLANTATION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; THROMBOSIS; BLOOD; CELLULAR IMMUNITY; CLINICAL TRIAL; COMPARATIVE STUDY; COMPLICATION; DONOR; GRAFT REJECTION; IMMUNOLOGY; KIDNEY TRANSPLANTATION; MIDDLE AGED; MORTALITY; PANCREATIC DISEASES; PATHOPHYSIOLOGY; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; RISK FACTOR; SURVIVAL RATE;

ADULT; ALLOGRAFTS; CASE-CONTROL STUDIES; COMPLEMENT C4B; FEMALE; FOLLOW-UP STUDIES; GRAFT REJECTION; HUMANS; IMMUNITY, CELLULAR; ISOANTIBODIES; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PANCREAS TRANSPLANTATION; PANCREATIC DISEASES; PEPTIDE FRAGMENTS; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE; THROMBOSIS; TISSUE DONORS;

EID: 84897116743     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/ajt.12624     Document Type: Article

References (25)

1. Ojo AO, Meier-Kriesche HU, Hanson JA, et al. The impact of simultaneous pancreas-kidney transplantation on long-term patient survival. Transplantation 2001; 71: 82-90.
2. Wolfe RA, Merion RM, Roys EC, Port FK., Trends in organ donation and transplantation in the United States, 1998-2007. Am J Transplant 2009; 9: 869-878.
3. Gruessner AC, Sutherland DE., Pancreas transplant outcomes for United States (US) cases as reported to the United Network for Organ Sharing (UNOS) and the International Pancreas Transplant Registry (IPTR), in Clinical Transplants 2008, pp 45-56. UCLA Tissue Typing Laboratory, Los Angeles, CA.
4. Norman SP, Kommareddi M, Ojo AO, Luan FL., Early pancreas graft failure is associated with inferior late clinical outcomes after simultaneous kidney-pancreas transplantation. Transplantation 2011; 92: 796-801.
5. Drachenberg CB, Papadimitriou JC, Farney A, et al. Pancreas transplantation: The histologic morphology of graft loss and clinical correlations. Transplantation 2001; 71: 1784-1791.
6. de Kort H, Roufosse C, Bajema IM, Drachenberg CB., Pancreas transplantation, antibodies and rejection: Where do we stand ? Curr Opin Organ Transplant 2013; 18: 337-344.
7. Colvin RB., Dimensions of antibody-mediated rejection. Am J Transplant 2010; 10: 1509-1510.
8. Drachenberg CB, Torrealba JR, Nankivell BJ, et al. Guidelines for the diagnosis of antibody-mediated rejection in pancreas allografts-Updated Banff grading schema. Am J Transplant 2011; 11: 1792-1802.
9. Schaar CG, van der Pijl JW, van Hoek B, et al. Successful outcome with a "quintuple approach" of posttransplant lymphoproliferative disorder. Transplantation 2001; 71: 47-52.
10. Pruijm MT, de Fijter HJW, Doxiadis II, Vandenbroucke JP., Preemptive versus nonpreemptive simultaneous pancreas-kidney transplantation: A single-center, long-term, follow-up study. Transplantation 2006; 81: 1119-1124.
11. Bruning JW, Claas FH, Kardol MJ, Lansbergen Q, Naipal AM, Tanke HJ., Automated reading of HLA-A,B,C typing and screening. The propidium iodide (PI) method. Hum Immunol 1982; 5: 225-231.
12. Solez K, Colvin RB, Racusen LC, et al. Banff '07 classification of renal allograft pathology: Updates and future directions. Am J Transplant 2008; 8: 753-760.
13. Muthusamy ASR, Mumford L, Hudson A, Fuggle SV, Friend PJ., Pancreas transplantation from donors after circulatory death from the United Kingdom. Am J Transplant 2012; 12: 2150-2156.
14. Garcia-Roca R, Samame J, Garcia-Criado MA, Real MI, Ricart MJ., Preservation of pancreas graft function after complete venous thrombosis: Report of four cases treated conservatively. Transplantation 2012; 93: 214-218.
15. Gaber LW., Pancreas allograft biopsies in the management of pancreas transplant recipients: Histopathologic review and clinical correlations. Arch Pathol Lab Med 2007; 131: 1192-1199.
16. de Kort H, Munivenkatappa R, Berger S, et al. Pancreas allograft biopsies with positive C4d staining and anti-donor antibodies related to worse outcome for patients. Am J Transplant 2010; 10: 1660-1667.
17. Klassen DK, Hoen-Saric EW, Weir MR, et al. Isolated pancreas rejection in combined kidney pancreas transplantation. Transplantation 1996; 61: 974-977.
18. Troxell ML, Koslin DB, Norman D, Rayhill S, Mittalhenkle A., Pancreas allograft rejection: Analysis of concurrent renal allograft biopsies and posttherapy follow-up biopsies. Transplantation 2010; 90: 75-84.
19. Bartlett ST, Schweitzer EJ, Johnson LB, et al. Equivalent success of simultaneous pancreas kidney and solitary pancreas transplantation: A prospective trial of tacrolimus immunosuppression with percutaneous biopsy. Ann Surg 1996; 224: 440-449.
20. Colling C, Stevens RB, Lyden E, et al. Greater early pancreas graft loss in women compared with men after simultaneous pancreas-kidney transplantation. Clin Transplant 2005; 19: 158-161.
21. Troppmann C, Gruessner AC, Dunn DL, Sutherland DE, Gruessner RW., Surgical complications requiring early relaparotomy after pancreas transplantation: A multivariate risk factor and economic impact analysis of the cyclosporine era. Ann Surg 1998; 227: 255-268.
22. Lu W, Pipeleers DG, Kloppel G, Bouwens L., Comparative immunocytochemical study of MHC class II expression in human donor pancreas and isolated islets. Virchows Arch 1996; 429: 205-211.
23. Loupy A, Hill GS, Suberbielle C, et al. Significance of C4d Banff scores in early protocol biopsies of kidney transplant recipients with preformed donor-specific antibodies (DSA). Am J Transplant 2011; 11: 56-65.
24. de Kort H, Willicombe M, Brookes P, et al. Microcirculation inflammation associates with outcome in renal transplant patients with de novo donor-specific antibodies. Am J Transplant 2013; 13: 485-492.
25. Niederhaus SV, Leverson GE, Lorentzen DF, et al. Acute cellular and antibody-mediated rejection of the pancreas allograft: Incidence, risk factors and outcomes. Am J Transplant 2013; 13: 2945-2955.